Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years

Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years

Submitted by admin on December 15, 2017 - 9:33am
Source: 
Endpoints
News Tags: 
Amicus
Pharma CEOs
FDA
Scott Gottlieb
migalastat
Fabry disease
Headline: 
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years

Do Not Allow Advertisers to Use My Personal information